01058nam2 22002651i 450 VAN001553120060109120000.088-348-5055-620040414d1995 |0itac50 baitaIT|||| |||||Studi 1982-1994Amedeo G. Contecon una lettera di Norberto BobbioTorinoGiappichelli1995XXXIX, P. 267-62721 cm.001VAN00155302001 Filosofia del linguaggio normativoAmedeo G. Conte210 TorinoGiappichelli215 v.21 cm.2TorinoVANL000001ConteAmedeo G.VANV010312159051Giappichelli <editore>VANV107921650ITSOL20230707RICABIBLIOTECA DEL DIPARTIMENTO DI GIURISPRUDENZAIT-CE0105VAN00VAN0015531BIBLIOTECA DEL DIPARTIMENTO DI GIURISPRUDENZA00CONS XXI.Ec.38 (2) 00 10590 20040414 Studi 1982-19941401504UNICAMPANIA04462oam 2201057zu 450 991101953800332120251116150834.01-280-55486-X97866105548670-470-85202-X0-470-84633-X(CKB)1000000000019180(SSID)ssj0000294353(PQKBManifestationID)11244142(PQKBTitleCode)TC0000294353(PQKBWorkID)10311742(PQKB)10835378(MiAaPQ)EBC4956270(Au-PeEL)EBL4956270(CaONFJC)MIL55486(OCoLC)55689482(EXLCZ)99100000000001918020160829d1999 uy engurcnu||||||||txtccrDrug regimen compliance : issues in clinical trials and patient management[Place of publication not identified]Wiley19991 online resource (203 pages)Bibliographic Level Mode of Issuance: Monograph0-471-97122-7 Drug Regimen Compliance Issues in Clinical Trials and Patient Management Edited by Jean-Michel Metry Aardex Ltd., Zug, Switzerland and Urs A. Meyer University of Basel, Switzerland A patient's non-compliance with drug regimens can render drugs ineffective. This not only causes problems for the patient but also large costs for health services. Despite a renewed interest in the subject over the past few years, there is still a dearth of new ideas and perspectives. This volume is written in response to this lack, and seeks to: Address key topics, such as regulatory issues and the role of compliance in clinical care Provide pointers for trials Provide guidelines for the management of patients Explore means by which compliance can be monitored Suggest the best ways to monitor patient management Drug Regimen Compliance: Issues in Clinical Trials and Patient Management provides the basis for future steps in improving patient compliance and will be invaluable to pharmacologists, toxicologists, pharmaco-epidemiologists, clinical trial scientists, medical economists and all those prescribing drug regimens.Patient complianceDosageDrugsClinical trialsClinical Trials as TopicPatient CompliancePharmaceutical PreparationsPatient Acceptance of Health CareEvaluation Studies as TopicHealth BehaviorEpidemiologic MethodsBehaviorInvestigative TechniquesHealth Care Evaluation MechanismsAttitude to HealthBehavior and Behavior MechanismsPublic HealthQuality of Health CareDelivery of Health CareHealth Care Quality, Access, and EvaluationEnvironment and Public HealthDelivery of Health CareMedical Professional PracticeHILCCMedicineHILCCHealth & Biological SciencesHILCCPatient complianceDosage.Drugs.Clinical trials.Clinical Trials as Topic.Patient Compliance.Pharmaceutical Preparations.Patient Acceptance of Health Care.Evaluation Studies as Topic.Health Behavior.Epidemiologic Methods.Behavior.Investigative Techniques.Health Care Evaluation Mechanisms.Attitude to Health.Behavior and Behavior Mechanisms.Public Health.Quality of Health Care.Delivery of Health Care.Health Care Quality, Access, and Evaluation.Environment and Public Health.Delivery of Health Care.Medical Professional PracticeMedicineHealth & Biological Sciences615/.1Mâetry Jean-MichelMeyer Urs AMétry Jean-MichelPQKBBOOK9911019538003321Drug regimen compliance : issues in clinical trials and patient management4422593UNINA